Back to results
US 2025/0026767 A1Published application
Crystalline forms of a par4 inhibitor
AssigneeBristol-Myers Squibb Company
InventorsRoxana F. Schlam, Nicolas Cuniere, Victoria A. Mbachu, Zhongping Shi, Petinka I. Vlahova
Life of this patent
Estimating the term…
Abstract
The present invention relates to co-crystals of the compound of formula (I). wherein the co-former molecule is succinic acid or citric acid. processes for the preparation of the co-crystal. pharmaceutical compositions thereof, and methods of using the co-crystals for treating or preventing thromboembolic disorders.
Claims15
A pharmaceutical composition comprising a co-crystal of the compound of Formula (1)
- and a co-former, wherein the co-former is succinic acid or citric acid, and a pharmaceutically acceptable carrier, and another therapeutic agent selected from an anti-platelet agent or an anticoagulated agent or a combination thereof.
Dependencies are inferred from the claim text.